| Literature DB >> 6622977 |
E L Kinney, J O Ballard, B Carlin, R Zelis.
Abstract
Amrinone, a new cardioactive drug, was administered for, on average, 27.9 d to 12 patients in severe congestive heart failure. Thrombocytopenia occurred in 4 patients, while a progressive decline in platelet numbers developed in 3 additional patients. The mechanism for these adverse effects of amrinone is unclear, but merits further study because of its frequency.Entities:
Mesh：
Substances：
Year: 1983 PMID： 6622977 DOI： 10.1111/j.1600-0609.1983.tb00665.x
Source DB: PubMed Journal: Scand J Haematol ISSN： 0036-553X